ID   HSC 72
AC   CVCL_AK37
AS   CVCL_G047
SY   HSC-72; HSC72; GM13022
DR   CLO; CLO_0013997
DR   BioSample; SAMN00802018
DR   Coriell; GM13022
DR   Wikidata; Q54896375
RX   PubMed=2805228;
RX   PubMed=6809308;
RX   PubMed=7994019;
RX   PubMed=14754601;
RX   PubMed=16166284;
CC   Sequence variation: Mutation; HGNC; HGNC:3582; FANCA; Unexplicit; Ex18-28del; Zygosity=Unspecified (PubMed=16166284).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
RX   PubMed=2805228; DOI=10.1093/carcin/10.11.2067;
RA   Arita I., Tachibana A., Takebe H., Tatsumi K.;
RT   "Predominance of Mex+ cells in newly-established human lymphoblastoid
RT   cell lines.";
RL   Carcinogenesis 10:2067-2073(1989).
//
RX   PubMed=6809308;
RA   Ishida R., Buchwald M.;
RT   "Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking
RT   and alkylating agents.";
RL   Cancer Res. 42:4000-4006(1982).
//
RX   PubMed=7994019; DOI=10.1182/blood.V84.12.3995.bloodjournal84123995;
RA   Liu J.M., Buchwald M., Walsh C.E., Young N.S.;
RT   "Fanconi anemia and novel strategies for therapy.";
RL   Blood 84:3995-4007(1994).
//
RX   PubMed=14754601;
RA   Clarke A.A., Gibson F.M., Scott J., Myatt N.E., Rutherford T.R.;
RT   "Fanconi's anemia cell lines show distinct mechanisms of cell death in
RT   response to mitomycin C or agonistic anti-Fas antibodies.";
RL   Haematologica 89:11-20(2004).
//
RX   PubMed=16166284; DOI=10.1158/0008-5472.CAN-04-1198;
RA   Araten D.J., Golde D.W., Zhang R.H., Thaler H.T., Gargiulo L.,
RA   Notaro R., Luzzatto L.;
RT   "A quantitative measurement of the human somatic mutation rate.";
RL   Cancer Res. 65:8111-8117(2005).
//